Prestigious Medical Journal Publishes Letter Showing Success of Hydroxychloroquine as COVID-19 Treatment

A recent letter published in the prestigious Journal of the American Medical Association (JAMA) has once again indicated the efficacy of hydroxychloroquine as a treatment for the COVID-19 virus.

JAMA published a research letter titled, “SARS-CoV-2 Infection Among Community Health Workers in India Before and After Use of Face Shields,” on Aug. 17. The author, Dr. M. Emmanuel Bhaskar, performed the research about face shields but made an interesting discovery about hydroxychloroquine along the way.

Health care workers in India who came down with COVID-19 while not using face shields were all treated successfully with hydroxychloroquine, which quickly alleviated their symptoms and restored the affected individuals to good health.

“The 12 infected workers were moved to care centers. Four developed desaturation and mild breathing difficulty and were treated with oral hydroxychloroquine and oxygen therapy; all 4 recovered,” Dr. Bhaskar noted in his research letter.

Medical whistleblowers who have fought against the reprehensible institutional conspiracy to suppress hydroxychloroquine have been attacked mercilessly as a result.

Big Pharma hitman and prophet of doom Dr. Anthony Fauci even attacked the peer-reviewed work of medical professionals because it went against his orders to demonize hydroxychloroquine at all costs, as Big League Politics reported:

The doctors responsible for a controversial pro-hydroxychloroquine study are defending their work after it was attacked by National Institute of Allergy and Infectious Diseases (NIAID) director Dr. Anthony Fauci at a recent Congressional hearing.

Drs. Adnan Munkarah and Steven Kalkanis wrote in an open letter that “a whole scientific field exists in which scientists examine how a drug is working in the real world to get as best an answer as they can as soon as possible,” which Dr. Fauci did not acknowledge in his complete dismissal of their work.

Munkarah works as the chief clinical officer of the Henry Ford Health System while Kalkanis works as the chief academic officer for the system. They are standing by their findings and refusing to buckle under the political pressure.

“Our promising Henry Ford treatment study should be considered as another important contribution to the other studies of hydroxychloroquine that describes what the authors found in our patient population,” Munkarah and Kalkanis wrote. “We — along with all doctors and scientists — eagerly support the need for randomized clinical trials.”

“Unfortunately, the political climate that has persisted has made any objective discussion about this drug impossible, and we are deeply saddened by this turn of events,” they wrote, noting they they believe that the science should “speak for itself.”

“To that end, we have made the heartfelt decision to have no further comment about this outside the medical community,” the doctors said.

Munkarah and Kalkanis call for more research to take place but believe that their findings could save lives and should not be discounted.

“As an early hot spot for the COVID-19 pandemic, we have seen and lived its devastating effects alongside our patients and families,” Munkarah and Kalkanis wrote.

The shills who have demonized hydroxychloroquine ought to have their licenses revoked, or perhaps even be jailed, for the needless suffering they have caused with their actions.

Our Latest Articles